IKBP1 Gene as A Potential Drug Target for IGF-1R Signaling Pathway

Target Name: IRAK1BP1

NCBI ID: G134728

IRAK1BP1

IKBP1 Gene as A Potential Drug Target for IGF-1R Signaling Pathway

The insulin-like growth factor (IGF) signaling pathway is a critical regulator of cellular growth and development, and its dysregulation has been implicated in numerous diseases, including obesity, type 2 diabetes, and cancer. The IGF-1 receptor (IGF-1R) is a key target for many therapies aimed at treating these diseases, and the IGF-1 receptor gene (IKBP1) has been identified as a promising biomarker for these diseases. In this article, we will explore the IKBP1 gene and its potential as a drug target.

The IGF-1R Signaling Pathway

The IGF-1R signaling pathway is a complex intracellular signaling pathway that involves the interactions of numerous proteins and signaling pathways. The IGF-1R receptor is a transmembrane protein that plays a critical role in regulating cellular growth and development. It is composed of an extracellular portion (IKBP1), a transmembrane portion (IKBP2), and an intracellular portion (IKBP3). The IGF-1R receptor is activated by the hormone insulin, which causes the translocation of the IGF-1 receptor to the endoplasmic reticulum, where it can then interact with the intracellular IGF-1 receptor (IKBP2).

The IGF-1R signaling pathway is involved in the regulation of cellular processes such as cell growth, differentiation, and survival. It is also involved in the regulation of cellular metabolism and energy homeostasis. The IGF-1R signaling pathway is activated by insulin, which causes the translocation of the IGF-1 receptor to the endoplasmic reticulum. Once there, the IGF-1 receptor can interact with the intracellular IGF-1 receptor (IKBP2), leading to the downstream regulation of various cellular processes.

The IKBP1 Gene and Its Potential as a Drug Target

The IKBP1 gene is a member of the superfamily of IGF-1 receptor (IGF-1R) gene family. It is a 14 kDa transmembrane protein that is expressed in various tissues and cells. The IKBP1 gene is responsible for the production of the IGF-1 receptor protein (IKBP1), which is the protein that plays a critical role in the IGF-1R signaling pathway.

The IKBP1 gene has been extensively studied for its potential as a drug target. One of the main reasons for this is the presence of several potential drug targets on the IKBP1 gene, including the IKBP1 intracellular domain, the IKBP1 extracellular domain, and the IKBP1 gene itself.

The IKBP1 Intracellular Domain

The IKBP1 intracellular domain is a 140 amino acid long region that is located within the cytoplasmic tail of the IKBP1 protein. It is involved in the regulation of cellular processes such as cell adhesion, migration, and survival. The IKBP1 intracellular domain has been implicated in several diseases, including cancer and neurodegenerative diseases.

The IKBP1 Extracellular Domain

The IKBP1 extracellular domain is a 280 amino acid long region that is located at the N-terminus of the IKBP1 protein. It is involved in the regulation of cellular processes such as cell adhesion, migration, and survival. The IKBP1 extracellular domain has been implicated in several diseases, including cancer and neurodegenerative diseases.

The IKBP1 Gene

The IKBP1 gene is a member of the superfamily of IGF-1R gene family. It is a 14 kDa transmembrane protein that is expressed in various tissues and cells. The IKBP1 gene is responsible for

Protein Name: Interleukin 1 Receptor Associated Kinase 1 Binding Protein 1

Functions: Component of the IRAK1-dependent TNFRSF1A signaling pathway that leads to NF-kappa-B activation and is required for cell survival. Acts by enhancing RELA transcriptional activity (By similarity)

The "IRAK1BP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IRAK1BP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets